These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 964279)

  • 21. The direct electrophysiologic effects of disopyramide phosphate in the transplanted human heart.
    Bexton RS; Hellestrand KJ; Cory-Pearce R; Spurrell RA; English TA; Camm AJ
    Circulation; 1983 Jan; 67(1):38-45. PubMed ID: 6401173
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Electrophysiologic effects of dopamine on the cardiac conduction system (author's transl)].
    Bischoff KO; Hager W; Bödeker K
    Z Kardiol; 1981 Sep; 70(9):643-51. PubMed ID: 7303803
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pharmacology of Norpace.
    Dean RR
    Angiology; 1975 Jan; 26(1 Pt 2):67-84. PubMed ID: 1115403
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects of disopyramide on normal and pathological atrioventricular conduction].
    Barnay C
    Ann Cardiol Angeiol (Paris); 1992 Oct; 41(8):449-53. PubMed ID: 1298185
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular actions of the dihydropyridine calcium antagonist nimodipine in the dog.
    Satoh K; Kawada M; Wada Y; Taira N
    Arzneimittelforschung; 1984; 34(5):563-8. PubMed ID: 6540573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Electrophysiologic effects of disopyramide in children.
    Kashani IA; Shakibi JG; Siassi B
    Jpn Heart J; 1980 Jul; 21(4):491-6. PubMed ID: 7420732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative effect of imolamine, lidocaine and disopyramide on experimental rhythm disorders and auriculoventricular conduction.
    Junien JL; Lakatos CR; Tine J
    Arzneimittelforschung; 1974 Nov; 24(11):1743-7. PubMed ID: 4141258
    [No Abstract]   [Full Text] [Related]  

  • 28. The electrophysiology of Norpace (Part II).
    Befeler B
    Angiology; 1975 Jan; 26(1 Pt 2):116-9. PubMed ID: 1115398
    [No Abstract]   [Full Text] [Related]  

  • 29. [Electrophysiologic characterization of propafenone in man].
    Masini G; Dianda R; Masini M
    G Ital Cardiol; 1984 Apr; 14(4):293-6. PubMed ID: 6735022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of the electrophysiological properties of intravenous bisoprolol in patients with and without coronary artery disease by programmed stimulation.
    Clémenty J; Samoyeau R; Coste P; Bricaud H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S169-74. PubMed ID: 11527122
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Study of hemodynamic and coronary effects induced by intravenous injection of disopyramide administered to coronary failure and congestive heart failure patients (author's transl)].
    Pornin M; Roland E; Lardoux H; Sellier P; Morin D; Ourbak P; Maurice P
    Therapie; 1981; 36(2):179-86. PubMed ID: 7292392
    [No Abstract]   [Full Text] [Related]  

  • 32. Combined effect of verapamil and disopyramide on induction of circus movement tachycardia in patients with pre-excitation.
    Matsuda H; Konishi T; Matsuyama E; Tamamura T; Kawai C
    Jpn Circ J; 1981 Oct; 45(10):1138-46. PubMed ID: 7299993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute effects of cocaine on catecholamines and cardiac electrophysiology in the conscious dog.
    Schwartz AB; Boyle W; Janzen D; Jones RT
    Can J Cardiol; 1988 May; 4(4):188-92. PubMed ID: 3395916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disopyramide: a study of its acute electrophysiological and haemodynamic effects [proceedings].
    Marrott PK; Ruttley MS; Winterbott JT; Muir JR
    Br J Clin Pharmacol; 1975 Aug; 2(4):373P. PubMed ID: 1234005
    [No Abstract]   [Full Text] [Related]  

  • 35. Intravenous disopyramide in acute myocardial infarction: a haemodynamic and pharmacokinetic study.
    Cameron J; Stafford W; Pritchard D; Norris R; Ravenscroft P
    J Cardiovasc Pharmacol; 1984; 6(1):126-31. PubMed ID: 6199595
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hemodynamic and electrophysiologic effects of the new calcium antagonist Ro 11-1781 (author's transl)].
    Bödeker K; Bischoff KO; Menken U; Hager W
    Z Kardiol; 1980 Nov; 69(11):790-6. PubMed ID: 7467662
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of the calcium antagonist nisoldipine on electrophysiologic parameters in the human].
    Klein HH; Nordbeck H; Kreuzer H
    Z Kardiol; 1983 Mar; 72(3):180-2. PubMed ID: 6858297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined effect of disopyramide and bethanechol: use of bethanechol to prevent anticholinergic side effects of disopyramide without reduction of antiarrhythmic efficacy.
    Konishi T; Kadoya M; Ikeguchi S; Sakai K; Tamamura T; Kawai C
    J Cardiovasc Pharmacol; 1989 Aug; 14(2):341-50. PubMed ID: 2476611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical and hemodynamic effects of disopyramide phosphate administered i.v. in cardiopathic subjects (author's transl)].
    Chiariello M; Santinelli V; Ferro G; Tari MG; Stanislao M; Condorelli M
    G Ital Cardiol; 1979; 9(9):975-83. PubMed ID: 520746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of intravenous disopyramide on the hemodynamics of patients hospitalized in intensive care units].
    Boland J; Lisin N; Marcelle R; Carlier J
    Arch Int Pharmacodyn Ther; 1976 Nov; 224(1):145-51. PubMed ID: 1015909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.